BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 20668220)

  • 21. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
    Harada H; Suzu S; Ito T; Okada S
    Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCID mouse as a model for transplantation studies.
    Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
    J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
    Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo engraftment potential of clinical hematopoietic grafts.
    Leung W; Ramírez M; Novelli EM; Civin CI
    J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1.
    Sato K; Nie C; Misawa N; Tanaka Y; Ito M; Koyanagi Y
    Vaccine; 2010 May; 28 Suppl 2():B32-7. PubMed ID: 20510741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.
    Wong WM; Sigvardsson M; Åstrand-Grundström I; Hogge D; Larsson J; Qian H; Ekblom M
    Stem Cells; 2013 Feb; 31(2):360-71. PubMed ID: 23165626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of human prothymocytes and xenogeneic thymopoiesis in hematopoietic stem cell-engrafted nonobese diabetic-SCID/IL-2rγnull mice.
    Parietti V; Nelson E; Telliam G; Le Noir S; Pla M; Delord M; Vanneaux V; Mohtashami M; Macintyre EA; Gluckman JC; Asnafi V; Zúñiga-Pflücker JC; Larghero J; Canque B
    J Immunol; 2012 Aug; 189(4):1648-60. PubMed ID: 22798679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
    Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
    J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells.
    Navarro-Montero O; Romero-Moya D; Montes R; Ramos-Mejía V; Bueno C; Real PJ; Menendez P
    Clin Immunol; 2012 Nov; 145(2):89-91. PubMed ID: 22964517
    [No Abstract]   [Full Text] [Related]  

  • 37. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
    Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
    J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
    Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
    Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-differentiated human committed T-lymphoid progenitors promote peripheral T-cell re-constitution after stem cell transplantation in immunodeficient mice.
    Eyrich M; Schreiber SC; Wollny G; Ziegler H; Schlenker R; Koch-Büttner K; Wölfl M; Schlegel PG; Schilbach K
    Eur J Immunol; 2011 Dec; 41(12):3596-603. PubMed ID: 21928276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perforin-independent rejection of transplanted human stem cells.
    Kaiser S; Kägi D; Ihorst G; Kapp U
    Clin Exp Immunol; 2006 Aug; 145(2):332-8. PubMed ID: 16879254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.